Josh Jennings

“I wanted to just start with a follow-up Just on your last comments, Joe, just on the innovation pipeline and the progress there, two things that stuck out that seemed a little bit new to me, maybe a little bit behind, but maybe you could just build out on this physical AI channel and how ultrasound on chip and…”

“Mike, I was hoping to just clarify just the outlook for the WAMGR as you've given a good high-level color on 27 and 28. In 2026, WAMGR is 7%.”

“Wanted to just ask about one of your slides, Ryan, where you talked about, I think, ablation being less than 10% of localized prostate cancer interventions today going to 40%. and it seemed like most of the share gains are assumed between surgery and radiation.”

“I was hoping to just follow up on some of the details on the rebuild of the commercial effort. And any help just thinking about, I guess, number of reps that are pushing in the vascular trauma channel today versus prior and how that could potentially ramp up?”

“Wanted to just follow up on Rick's questions, just on margins.”